Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency (Detail Textuals)

v3.5.0.2
Stockholders' Deficiency (Detail Textuals) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Stockholders' Equity Note [Abstract]        
Stock-based compensation expense related to warrants $ 23,627 $ 90,159 $ 115,589 $ 56,759
Unrecognized stock-based compensation expense $ 68,661   $ 68,661  
Unrecognized stock-based compensation expense recognized over approximately     8 months 12 days